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Background: Gastrointestinal endoscopy plays a crucial role in the diagnosis and management of gastrointestinal
disorders. When endoscopy is indicated during pregnancy, concerns about the effects on pregnancy outcome
often arise. The aim of this study was to assess whether lower gastrointestinal endoscopies (LGEs) across all three
trimesters of pregnancy affects pregnancy outcomes.
Methods: A systematic literature search was performed using Embase (including MEDLINE), Medline OvidSP, Cochrane
Central Register of Controlled Trials, Web-of-Science, Google scholar and Pubmed. All original research articles from 1990
until May 2014 involving pregnant women who underwent LGE for any indication were included. Adverse pregnancy
events like spontaneous abortion, preterm birth and fetal demise were assessed for a temporal and etiological relation
with the LGE.
Results: In total, 5514 references were screened by two independent reviewers. Eighty-two references met the inclusion
criteria and were selected. Two retrospective, controlled studies, one uncontrolled study and 79 case reports were
identified. In the three studies, birth outcomes did not differ between women undergoing LGE during pregnancy,
compared to women that had an indication for LGE but in whom LGE was not performed because of pregnancy. In 79
case reports, 92 patients are described who underwent 100 LGE’s during pregnancy. LGEs performed in all trimesters
(n = 32, 39 and 29) were both temporally and etiologically related to 1, 3 and 2 adverse events, respectively.
Conclusion: Based on the available literature, this review concludes that lower gastrointestinal endoscopy during
pregnancy is of low risk for mother and child in all three trimesters of pregnancy.
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Gastrointestinal endoscopy plays a crucial role in the
diagnosis and management of acute and chronic
gastrointestinal disorders. In general, sigmoidoscopy
and colonoscopy are regarded of low risk, because of the
very low rate of serious complications following lower
gastrointestinal endoscopy (LGE) [1,2]. Endoscopic
procedures during pregnancy are less common, and
although an estimated 6000 pregnant women in the United
States annually have an indication for endoscopy, the safety
of endoscopy during pregnancy remains unknown [3].* Correspondence: a.delima@erasmusmc.nl
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unless otherwise stated.LGE during pregnancy raises important safety questions,
including whether medication or bowel preparation is
associated with placental abruption or fetal trauma during
endoscopic intubation [4] and fetal demise due to maternal
hypoxia [4], hypotension or cardiac arrhythmias [5].
Despite the paucity of data, oesophagoduodenoscopy [6,7]
and sigmoidoscopy [8] are considered relatively safe during
pregnancy. The safety of colonoscopy during pregnancy
remains more elusive and under debate. In recent ASGE
guidelines LGE is regarded of low risk during pregnancy,
and it is concluded that if possible this should be deferred
to the second trimester [9]. Recently, we had to perform
several endoscopies in other trimesters and therefore we
decided to perform a systematic literature search to assess
the effect of the timing of LGE during pregnancy onl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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stillbirth and premature labor.
Methods
Search strategy
A systematic database search for citations about LGE during
pregnancy was performed by the first author (ADL) and an
information specialist (WMB) on May 26th 2014. This
search was performed in the following databases: Embase
(including MEDLINE), Medline OvidSP, Cochrane Central
Register of Controlled Trials, Web-of-Science, Google
scholar and Pubmed. The detailed digital search strategy is
provided in the Additional file 1.
Review and study selection process
Titles and abstracts identified through the search
strategy were assessed by two independent reviewers
for potential eligibility. All original research articles,
including case reports, were included. References were
excluded on title and abstract based on the following
exclusion criteria: all references published before 1990, all
references not in English, all references regarding different
subjects, conference proceedings and animal studies.
Disagreements were settled in consensus and, if necessary,
after discussion with a third independent reviewer. The
manuscripts deemed potentially eligible for inclusion were
obtained for full text review. The full texts were assessed
by the two independent reviewers ((1) ADL and (2) BG
and PHAW), using pre-defined eligibility criteria. Articles
were included when the study population consisted of at
least one pregnant female and LGE was performed
during pregnancy. Articles on ectopic pregnancy were
excluded, as well as articles without outcome infor-
mation on the mother and the child. Discussions with
the third independent (CJW) reviewer were used to
resolve disagreements.
Data extraction
Data from the eligible reports was extracted using a
standardized form by the primary reviewers. Differences
in the extracted data were resolved through consensus
or, if necessary, discussion with the third independent
reviewer. For each study, the following data was extracted
considering the following:
1. Procedure (type of endoscopy, gestational week of
endoscopy)
2. Participants (including age, indication for
endoscopy)
3. Interventions (additional surgery, medical treatment,
gestational week of other interventions)
4. Outcomes (including birth outcomes, fetal adverse
events, maternal adverse events, gestational week of
adverse events)Definitions
Sigmoidoscopy was defined as endoscopic intubation no
further than the splenic flexure, and colonoscopy was
defined as endoscopic intubation beyond the splenic
flexure.
Miscarriages or spontaneous abortion were defined as
fetal loss prior to 20th gestational week. Stillbirth or fetal
demise was defined as fetal loss beyond the 20th gestational
week. Premature delivery was defined as delivery before
gestational week 37.
A temporal relation between an adverse event and LGE
was found as plausible if the adverse event occurred within
1 week of the LGE and defined as unlikely when the
adverse event occurred more than 1 week after endoscopy.
An etiological relation was found plausible if a temporal
relation existed and, in addition, based on sound, medical
reasoning the adverse event could be linked to the LGE.
Etiological relations were classified on an ordinal scale as:
unlikely, possible, probable and likely. These relations
were determined in consensus, based on the following
definitions.
Unlikely relation: LGE or its preparation or sedation
cannot explain maternal/fetal adverse event, based on
sound, medical reasoning. Elective abortions and induced
labor or elective caesarean sections were all classified as
unlikely related to LGE.
Possible relation: LGE or its preparation or sedation
could explain maternal/fetal adverse event, however in
between LGE and the occurrence of the adverse event
another intervention was also performed (e.g. laparotomy).
Probable relation: LGE or its preparation or sedation
could explain maternal/fetal adverse event, no other
interventions between LGE and adverse event were
performed, however, the underlying maternal disease
could still also explain the adverse event.
Likely relation: LGE or its preparation or sedation
could explain maternal/fetal adverse event, no other
interventions between adverse event were performed,
maternal disease does not seem etiologically related
to the adverse event.
Results
The search yielded a total of 5514 citations. After reviewing
title and abstracts, 980 manuscripts were selected for
further review. After review of the full text, 75 articles were
included, including one retrospective uncontrolled study,
two retrospective, controlled studies and 72 case reports
or series. An additional non-systematic search yielded
another 7 case reports, resulting in a total of 82 articles
(See flowchart in Figure 1).
Description of the studies
An uncontrolled, retrospective, multicenter study in 1995
[10], which was published again one year later as an
Embase (including
MEDLINE), Medline 
OvidSP, Cochrane Central 
Register of Controlled 
Trials, Web-of-Science,
Google scholar and 
Pubmed:
5514 articles
Eligible for full tekst
screening:
980 articles
Excluded on
title/abstract:
4534 articles
Included articles:
75 articles
Included articles:
82 articles
Excluded on full tekst:
905 articles
Non-systematically
aquired:
7 articles
Figure 1 Flowchart of study selection process.
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pregnant patients undergoing 48 sigmoidoscopies and 8
pregnant patients undergoing 8 colonoscopies. There were
no differences in birth outcomes between the pregnant
patients undergoing endoscopy during pregnancy com-
pared to the pregnant patients not undergoing endoscopy
during pregnancy. Both groups had similar indications for
endoscopy. In addition, there were no differences in birth
outcomes compared to the national American rates at that
time. No adverse maternal events were reported following
endoscopy. Following sigmoidoscopy, 4 voluntary abortions
and 3 fetal demises occurred. All fetal demises were tem-
porally and etiologically unrelated with the endoscopies.
Following colonoscopy, there was one voluntary abortion
and one fetal demise, both also temporally and etiologically
unrelated with the colonoscopy.
In 2010, a study focusing exclusively on colonoscopies
during pregnancy was published [3]. This retrospective,
controlled cohort study reported on the safety and
efficacy of colonoscopy in 20 pregnant patients. These
pregnant patients were matched 1:1 with 20 pregnant
controls with the same indication for colonoscopy but
who did not undergo colonoscopy due to pregnancy.The study group was also compared to the pregnancy out-
comes of the American national average. The majority of
colonoscopies were performed in the second trimester of
pregnancy (n = 16), with only 2 colonoscopies performed
in respectively the first and third trimester. The study
group trended towards worse pregnancy outcomes like
stillbirth, premature delivery, low birth weight, low APGAR
score, congenital defects and infant death after live birth,
compared to the American national average. These non-
significant differences can be attributed to the underlying
illness in the study group according to the authors. When
compared to the control group as described above, the
study group tended to have slightly better fetal outcomes
compared to the control group in terms of premature
delivery, low birth weight, APGAR scores, congenital
defects, neonatal ICU stay, infant postpartum hospitalization
and infant death after live birth.
Description of the case reports
The 79 case reports describing 92 patients are summarized
and categorized per trimester in Tables 1, 2 and 3.
Indications for LGE
Roughly, five major indications for endoscopy could be
distinguished: (1) IBD and other colitis, (2) malignancy,
(3) volvulus or incarcerated uterus, (4) non-malignant
colonic obstruction and (5) gastrointestinal bleeding.
Adverse events related to LGE
All temporally and etiologically related adverse events
identified from the case reports are summarized in Table 4.
First trimester
In the first trimester, 32 LGEs were performed in 30
patients. All complications following LGE in the first
trimester are listed in Table 1. Three adverse events
occurred within 1 week of the LGE. In one case report
[20], the patient underwent sigmoidoscopy at gestational
week 10 and the patient had an incomplete spontaneous
abortion at 10.4 weeks. The patient suffered from severe
rectal bleeding due to a heterotopic, abdominal pregnancy
protruding the terminal ileum. This adverse event could
possibly be attributed to the LGE, because this patient also
underwent laparotomy after the LGE and suffered from
severe gastrointestinal bleeding. The other two temporally
related adverse events in the first trimester were both
elective abortions, and were therefore classified as
etiologically unrelated to the LGE [17,18].
Second trimester
In the second trimester, 39 endoscopies were performed
in 35 patients. All complications following LGE in the
second trimester are listed in Table 2. Six adverse events
occurred within one week of LGE. Three cases reported
Table 1 First trimester fetal and maternal adverse events (wk 1–12)
Indication N Maternal adverse
events
Pregnancy
outcome
Spontaneous
abortion
Other fetal adverse events Temporal relation with
endoscopy?
Etiological relation with
endoscopy?
Sigmoidoscopy
IBD & colitis other [11-16] 6 None Live birth (n = 6) No (n = 6) 3 premature births
(34, 28 and 25.5 wks)
No No
Malignancy [17,18] 3 (in 2 pts) None Elective abortion (n = 2) No (n = 2) Elective abortion
(unwanted pregnancies)
Yes (n = 2) No
Volvulus and incarcerated uterus [19] 1 None No pregnancy losses No (n = 1) Not reported No No
Non-malignant colonic obstruction 0 - - - - - -
Gastrointestinal bleeding [20] 1 None Incomplete
abortion (n = 1)
Yes, incomplete
abortion at 10.4
wks (n = 1)
- Yes Possible, abdominal
pregnancy, laparotomy
after sigmoidoscopy
Colonoscopy
IBD & colitis other [21-27] 12 None Live births (n = 11),
stillbirth (n = 1)
No (n = 12) 2 premature births (32
and 33 wks), 1 stillbirth
(22 wks)
Unclear, paper fails to
show which outcome
belongs to which patient
No, authors do not link
adverse events to
endoscopy
Malignancy [28-32] 5 Maternal death
(n = 1), none
(n = 4)
Live birth (n = 5) No (n = 5) 3 premature births
(33, 33.6 and 34 wks)
No No
Volvulus and incarcerated uterus 0 - - - - - -
Non-malignant colonic obstruction [33] 1 None Live birth (n = 1) No (n = 1) None No No
Gastrointestinal bleeding [34,35] 3 (in 2 pts) None Live birth (n = 2) No (n = 2) None No No
Total 32
IBD = Inflammatory Bowel Disease.
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Table 2 Second trimester fetal and maternal adverse events (wk 13–26)
Indication N Maternal adverse events Pregnancy
outcome
Premature births Other fetal adverse
events
Temporal relation with
endoscopy?
Etiological relation with
endoscopy?
Sigmoidoscopy
IBD & colitis other [36-41] 8 (in 6 pts) None (n = 6) Live birth (n = 5),
not reported (n = 1)
Yes (n = 1),
no (n = 4),
not reported
(n = 1)
Low birth weight
(n = 2), not reported
(n = 1)
No No
Malignancy [42-47] 6 Maternal death
(n = 2), unreported
(n = 1), none (n = 3)
Live birth (n = 3),
elective abortion
(n = 2), fetal death
(n = 1)
Yes (n = 3) all
prostaglandin
induced or elective
caesarean section
Low birth weight (n = 3) Yes (n = 3), no (n = 3) Unlikely (n = 3)
Volvulus and incarcerated
uterus [19,48,49]
7 (in 5 pts) None Live birth (n = 5) None Low birth weight (n = 1) No No
Non-malignant colonic
obstruction [50]
1 None Live birth (n = 1) Yes (n = 1) Vaginal delivery at 35 wks No No
Gastrointestinal bleeding [51] 1 None Stillbirth (n = 1) Yes (n = 1) Fetal demise at 20 wks
within several hours of
surgery
Yes Possible, however the
patient also underwent
emergency surgery and
suffered from a massive
hemorrhage
Colonoscopy
IBD & colitis other [24,52-54] 6 None Live birth (n = 5),
stillbirth (n = 1)
Yes(n = 2),
No (n = 4)
Unreported (n = 2),
none (n = 4)
Unclear, paper fails to
show which outcome
belongs to which patient
Unclear, authors do not link
adverse event (stillbirth) to
endoscopy
Malignancy [55-60] 6 None (n = 3),
maternal death
postpartum (n = 2),
disease progression
postpartum (n = 1)
Live birth (n = 4),
unreported (n = 1),
fetal death at
26 wks(n = 1)
Yes (n = 3)
at 30, 34
and 36 wks
Low birth weight
(n = 3), neonatal
care unit admittance
postpartum (n = 2)
Yes, fetal death was
within 1 week of
colonoscopy, premature
births no temporal
relation with endoscopy
Probable, but fetal death
most likely due to maternal
deterioration because of
cancer progression and sepsis
Volvulus and incarcerated
uterus [61]
1 Not reported Live birth (n = 1) No None No No
Non-malignant colonic
obstruction [62]
1 Mother remained
hospitalized for
50 days after delivery
Stillbirth (n = 1) Yes (n = 1) Evidence of spontaneous
labour, physicians terminated
the pregnancy at 15 wks
Yes Probable, however colonic
perforation was feared due
to worsening distention of
the bowel, not per se due
to the LGE
Gastrointestinal bleeding
[34,63]
2 None (n = 2) Live birth (n = 1),
not reported (n = 1)
No (n = 1), not
reported (n = 1)
Not reported (n = 1),
None (n = 1)
No No
Total 39
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Table 3 Third trimester fetal and maternal complications (27–42 wks)
Indication N Maternal adverse events Pregnancy outcome Premature birth Fetal adverse events Temporal relation
with endoscopy?
Etiological relation with
endoscopy?
Sigmoidoscopy
IBD & colitis other [11,64,65] 3 None (n = 2), subtotal
colectomy with
ileostomy after
delivery (n = 1)
Live birth (n = 3) No (n = 1),
Yes (n = 2)
Premature births (28 and
34 wks), low birth weight
(1850 and 1054 g)
No (n = 2),
yes (n = 1)
Likely, after sigmoidoscopy
colonic perforation was
suspected, this led to an
emergency caesarean
section.
Malignancy [66-70] 5 Not reported (n = 3),
death 12 months after
hemicolectomy (n = 1),
1,5 years after delivery
discovery of pulmonary
metastases (n = 1)
Live birth (n = 5) Yes (n = 4),
No (n = 1)
Premature births at 34, 34,
31 and 33 wks, all deliveries
were elective, low birth
weight reported (n = 2)
No Unlikely
Volvulus and incarcerated
uterus [49,71-73]
5 (in 4 pts) None Live birth (n = 4) None None Yes (n = 1) Unlikely
Non-malignant colonic
obstruction [74,75]
2 None Live birth (n = 1),
not reported (n = 1)
Yes (n = 1) Elective caesarean section
(n = 1), Not reported (n = 1)
Yes (n = 1) Unlikely
Gastrointestinal bleeding 0 - - - - - -
Colonoscopy
IBD & colitis other [52,76] 2 Intensive care unit
admittance postpartum
(n = 1), none (n = 1)
Live birth (n = 1),
not reported (n = 1)
Yes (n = 1), not
reported (n = 1)
Premature birth (32 wks)
with low birth weight
2175 grams
No Unlikely
Malignancy [77-84] 8 None (n = 4), maternal
death after delivery
due to disease
progression (n = 4)
Live birth (n = 8) Yes (n = 8) Premature births by elective
caesarean section (n = 4),
spontaneous premature
birth (n = 4)
Yes (n = 1),
no (n = 7)
Unlikely
Volvulus and incarcerated uterus 0 - - - - - -
Non-malignant colonic
obstruction [85,86]
3 (in 2 pts) None Live birth (n = 1),
live twin birth (n = 1)
Yes (n = 1) Spontaneous premature
birth of twins at wk 34
Yes Possible, however nifedipine
was also stopped around
time of LGE
Gastrointestinal bleeding [87] 1 None Elective termination
at 34 wks
Yes Not reported No Unlikely
Total 29
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Table 4 Summary of adverse events (AEs) etiologically related to LGE
Week of LGE Week of AE Type of AE Other intervention between LGE and AE Likeliness relation
Sigmoidoscopy
10 10.4 Incomplete spontaneous abortion Laparotomy Possible
20 20 Fetal death Laparotomy Possible
28 28 Suspected perforation leading to
emergency caesarean section
Laparotomy and caesarean
section at same time
Likely
Colonoscopy
25 26 Fetal death None Probable
15.2 15.3 Pregnancy termination by physicians None Probable
34.0 34.1 Premature spontaneous labour Nifedipine cessation Possible
De Lima et al. BMC Gastroenterology  (2015) 15:15 Page 7 of 11three fetal deaths within one week of endoscopy. In
the first case [51], the patient suffered from massive
hematochezia due to multiple bleeding foci in the
cecum and terminal ileum and underwent laparotomy
shortly after colonoscopy. Fetal demise was evident
several hours after surgery. This adverse event is possibly
related to the LGE. The second patient was diagnosed
with an advanced stage of colorectal carcinoma with liver
metastases and ascites during pregnancy. After colonos-
copy, the patient deteriorated rapidly and seven days after
endoscopy fetal death was observed by ultrasonography.
The mother died within 2 weeks after delivery [55]. This
adverse event can probably be related to the LGE. The
third case demonstrated a patient with progressive colonic
distension caused by colonic pseudo-obstruction (Ogilvie’s
syndrome). After colonoscopy, radiologic studies showed
no evidence of colonic perforation, but the day after
colonoscopy the abdominal distension progressed further,
the patient went into spontaneous labor and the physicians
decided to terminate the pregnancy [62]. This adverse event
could also probably be related to the LGE. Two patients
diagnosed with colorectal adenocarcinoma during preg-
nancy underwent elective abortion within one week of LGE
in gestational week 16 and 20 [42,43] and in one patient
labor was induced with prostaglandin in gestational week
26 [44]. These three adverse events were therefore classified
as unlikely related to the LGE.
Third trimester
In the third trimester, 27 patients underwent 29 endos-
copies. All complications following LGE in the third tri-
mester are listed in Table 3. Four case reports demonstrated
adverse events within one week of endoscopy. These four
cases were likely related in one, possibly related in one and
unlikely related in two of the cases. The first case describes
a patient who was diagnosed with ulcerative colitis upon
sigmoidoscopy in the sixth week of pregnancy. In the 28th
week of pregnancy she exhibited signs of exacerbation and
she underwent another sigmoidoscopy with biopsies.
Following the second sigmoidoscopy, colonic perforationwas suspected and an emergency caesarean section and ex-
ploratory laparotomy was performed. No colonic perfor-
ation was seen intraoperatively [11]. A live, healthy baby of
1054 g was delivered. This adverse event was classified as
likely to be related to the LGE. The second patient was
33 weeks pregnant with twins, when she underwent
two subsequent colonoscopies for the treatment and
decompression of acute colonic pseudo-obstruction.
She was already being treated with nifedipine upon
presentation for inhibition of premature contractions,
and nifedipine was stopped upon hospital admission.
One day after the last colonoscopy at gestational week 34,
she went into spontaneous labor and delivered healthy
twins [85]. This adverse event is possibly related to the
LGE. The third patient underwent sigmoidoscopy because
of abdominal pain and distention in the 34th gestational
week. Upon endoscopy, the splenic flexure appeared nec-
rotic and the patient immediately underwent laparotomy
with an emergency caesarean section [74]. This adverse
event is unlikely related to the LGE. The fourth patient
was diagnosed with a malignancy of unknown origin, and
in the metastatic workup a colonoscopy was performed in
gestational week 32. A poorly differentiated signet cell
adenocarcinoma of the transverse colon was found,
and after 4 days of dexamethasone administration for
fetal lung maturation an elective caesarean section
was performed [77]. This adverse event was unlikely
related to the LGE.
One case report and one case series did not report at
what gestational week the LGE was performed and were
therefore not categorized. These case reports describe
three pregnant women with IBD who underwent sigmoid-
oscopy for IBD disease assessment. One woman delivered
a live baby of 1008 gram prematurely at 28.1 weeks
[88]. A temporal relation was not found, and the
authors do not link this adverse event to the sigmoidos-
copy. In the case series, 2 out of 5 women underwent
sigmoidoscopy, and one woman delivered a live baby
prematurely. It is not reported if this woman underwent
LGE [89].
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A sensitivity analysis was performed by elongating the
time span for the temporal relation between adverse
events and the LGE. Initially, all adverse events were
temporally related to the LGE if they occurred within
one week after the LGE, however this analysis will classify
all adverse events within three weeks of the LGE as
temporally related. In the first trimester, this approach
yielded no extra temporally related adverse events. In the
second trimester, one additional temporally related
adverse event was detected. In this case, the mother was
diagnosed with advanced colorectal carcinoma during
pregnancy and died together with the fetus two weeks
after hospital admission around gestational week 23 [45].
This adverse event was unlikely to be related to the LGE.
Finally, in the third trimester another seven temporally
related adverse events were detected. Six premature
deliveries were unlikely related to the LGE, as they
were all elective caesarean sections [76,78-80,87] or
induced labor [66]. The seventh patient suffered from
ulcerative colitis and underwent LGE for assessment
of disease activity in gestational week 32. Endoscopy
showed the colon to be severely inflamed and two weeks
later the patient delivered a premature baby of 1850 grams
[64]. This adverse event is classified as probably related to
the LGE.
Discussion
The objective of this systematic review was to assess the
risk of LGE in all trimesters of pregnancy.
Three retrospective cohort studies investigated the
safety of LGE during pregnancy. Of these, two studies
describe the same study population, and report no differ-
ence in birth outcomes and adverse events between the
study and the control group. None of the reported fetal and
maternal adverse events showed a temporal or an etiological
relation with the LGE [8,10]. Although these studies report
no adverse events related to LGE, it remains unclear in
which trimester the LGE was performed.
The third study [3], on which the recent endoscopy
guidelines [9] seem to be based, focuses exclusively on
colonoscopies during pregnancy. The authors conclude
that colonoscopies during pregnancy are probably safe
to perform, but limit their conclusion to the second
trimester because of insufficient data in the first and
third trimester. Prior to this study in 2010, the authors
identified 17 case reports on colonoscopy during
pregnancy and add these data to their own conclusion
that there is still insufficient evidence to claim safety
of colonoscopy in each trimester [3].
Overall, this systematic review identified 79 case
reports, describing 100 LGE’s in 92 patients. In total
six (6.0%) temporally and etiologically related adverse
events were found.Out of these 79 case reports 42 case reports described
51 colonoscopies in 49 patients during pregnancy,
distributed equally across the trimesters (21, 16 and 14
colonoscopies in trimester 1, 2 and 3, respectively).
Three temporally and etiologically related adverse events
occurred in these 49 patients (6.1%), of which 1 occurred
in the third trimester [85] and was possibly related and 2
occurred in the second trimester [55,62] and were
probably related to the colonoscopy (see Table 2 and 3).
Although the evidence level of these case reports is low,
these data suggest colonoscopy during pregnancy is prob-
ably safe to perform. This finding is in agreement with the
primary conclusion of the included studies. However, the
data from our included case reports in fact suggests colon-
oscopy to be of similar low risk in each trimester. In
addition, we identified 37 case reports, describing 49
sigmoidoscopies in 43 patients. In this subset of patients,
also three temporally and etiologically related adverse
events occurred in these 43 patients (7.0%), of which one
occurred in the first [20] and one in the second trimester
[51] and were both possibly related, and one in the third
trimester [11] and was likely related to the sigmoidoscopy.
Furthermore, in our view, postponing LGE during
pregnancy or even until after pregnancy might hamper
the patient and the pregnancy more than the LGE itself.
A diagnostic delay will inevitably induce an unwanted
therapeutic delay, and therefore the risks of LGE during
pregnancy must be weighed against the expected bene-
fits. Consequently, elective endoscopies (e.g. for screen-
ing purposes) should be deferred until after pregnancy.
Safety research during pregnancy is always a chal-
lenging field, as prospective studies are rarely, and ex-
perimental studies are almost never performed. Therefore,
we rely on retrospective studies and case series to
support our conclusions and guidelines. Although the
evidence in this systematic review is anecdotal and
more controlled studies are needed, this review appears to
be the most extensive overview of available studies on
this subject.
The major limitation of this exhaustive systematic
review is the lacking of a solid control group for the
summarized case reports. Furthermore, the majority
of case reports describe severely ill patients in whom
the true effect of LGE during pregnancy is hard to
untangle. In addition, none of the case reports primarily
aimed to describe the effect of LGE during pregnancy,
rendering these effects subject to our interpretation. Type
of bowel preparation and sedation are not mentioned in
the majority of included case reports, and their effects
cannot be taken into consideration. Also, mild and
more subtle adverse events due to LGE could have
been easily missed. We therefore focused on serious
adverse events like spontaneous abortion, stillbirth
and premature delivery.
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In conclusion, we underline that LGE should only be
performed during pregnancy when strongly indicated
and is probably of low risk. Postponing LGE during
pregnancy to the second trimester or puerperium however,
is unnecessary and in most cases unwanted because of the
therapeutic delay which might hamper the pregnancy
outcomes more than the LGE itself.
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